Skip to content

Clinical Trial of Electroacupuncture for Delayed Sleep-Wake Phase Disorder

Clinical Trial of Electroacupuncture for Delayed Sleep-Wake Phase Disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001211
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delayed Sleep-Wake Phase Disorder

Interventions

Control group:Sham acupuncture
Experimental group:Electroacupuncture

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for delayed sleep-wake phase disorder as outlined in the ICSD-3-TR; 2. Aged = 18 and = 65 years old male or female; 3. MEQ scale score = 41 points; 4. Have not received any form of acupuncture treatment; 5. Understand and agree to participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe heart liver kidney blood or respiratory system diseases; uncontrolled infectious diseases; 2. History of severe mental disorders (e.g. bipolar disorder schizophrenia etc.); 3. Individuals with infections or injuries near the selected acupoints that preclude acupuncture treatment; 4. Pregnant women and lactating women; 5. Individuals with shift work schedules within the 2 weeks prior to screening and throughout the study period or those planning to travel to locations more than two time zones away; 6. Individuals with a polysomnography (PSG) results showing an apnea-hypopnea index (AHI) = 15 events per hour and/or periodic limb movements accompanied by arousal = 15 events per hour and/or rapid eye movement (REM) sleep with muscle atonia and/or dream-related behaviors; 7. Individuals who have been taking sedative-hypnotic medications for =3 months or are currently participating in other clinical trials related to sleep disorders.

Design outcomes

Primary

MeasureTime frame
Morningness Eveningness Questionnaire;

Secondary

MeasureTime frame
Actigraphy;Hamilton Anxiety Scale;Fatigue Severity Scale;Hamilton Depression Scale;Pittsburgh sleep quality index;Sleep diary;Epworth sleepiness scale;

Countries

China

Contacts

Public ContactXintong Yu

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Shanghai University of Traditional Chinese Medicine

yuxt1117@163.com13371973572

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026